Human Chorionic Gonadotropin (HCG) Market Report – Research, Industry Analysis Reports and Market Demands

Global Human Chorionic Gonadotropin (HCG) Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Human Chorionic Gonadotropin (HCG) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Product
- 1.4.2 Natural Source Extraction
- 1.4.3 Recombinant DNA Technology
1.5 Market by End User
- 1.5.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by End User
- 1.5.2 Female Infertility Treatment
- 1.5.3 Oligospermic Treatment
- 1.5.4 Cryptorchidism Treatment
- 1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Human Chorionic Gonadotropin (HCG) Market Size
- 2.1.1 Global Human Chorionic Gonadotropin (HCG) Revenue 2014-2025
- 2.1.2 Global Human Chorionic Gonadotropin (HCG) Sales 2014-2025
2.2 Human Chorionic Gonadotropin (HCG) Growth Rate by Regions
- 2.2.1 Global Human Chorionic Gonadotropin (HCG) Sales by Regions
- 2.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Human Chorionic Gonadotropin (HCG) Sales by Manufacturers
- 3.1.1 Human Chorionic Gonadotropin (HCG) Sales by Manufacturers
- 3.1.2 Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturers
- 3.1.3 Global Human Chorionic Gonadotropin (HCG) Market Concentration Ratio (CR5 and HHI)
3.2 Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers
- 3.2.1 Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers (2014-2019)
- 3.2.2 Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers (2014-2019)
3.3 Human Chorionic Gonadotropin (HCG) Price by Manufacturers
3.4 Human Chorionic Gonadotropin (HCG) Manufacturing Base Distribution, Product Types
- 3.4.1 Human Chorionic Gonadotropin (HCG) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Human Chorionic Gonadotropin (HCG) Product Type
- 3.4.3 Date of International Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Human Chorionic Gonadotropin (HCG) Sales by Product
4.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Product
4.3 Human Chorionic Gonadotropin (HCG) Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Human Chorionic Gonadotropin (HCG) Breakdown Data by End User

6 North America

6.1 North America Human Chorionic Gonadotropin (HCG) by Countries
- 6.1.1 North America Human Chorionic Gonadotropin (HCG) Sales by Countries
- 6.1.2 North America Human Chorionic Gonadotropin (HCG) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Human Chorionic Gonadotropin (HCG) by Product
6.3 North America Human Chorionic Gonadotropin (HCG) by End User

7 Europe

7.1 Europe Human Chorionic Gonadotropin (HCG) by Countries
- 7.1.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Countries
- 7.1.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Human Chorionic Gonadotropin (HCG) by Product
7.3 Europe Human Chorionic Gonadotropin (HCG) by End User

8 Asia Pacific

8.1 Asia Pacific Human Chorionic Gonadotropin (HCG) by Countries
- 8.1.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Countries
- 8.1.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Human Chorionic Gonadotropin (HCG) by Product
8.3 Asia Pacific Human Chorionic Gonadotropin (HCG) by End User

9 Central & South America

9.1 Central & South America Human Chorionic Gonadotropin (HCG) by Countries
- 9.1.1 Central & South America Human Chorionic Gonadotropin (HCG) Sales by Countries
- 9.1.2 Central & South America Human Chorionic Gonadotropin (HCG) Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Human Chorionic Gonadotropin (HCG) by Product
9.3 Central & South America Human Chorionic Gonadotropin (HCG) by End User

10 Middle East and Africa

10.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) by Countries
- 10.1.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Countries
- 10.1.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) by Product
10.3 Middle East and Africa Human Chorionic Gonadotropin (HCG) by End User

11 Company Profiles

12 Future Forecast

12.1 Human Chorionic Gonadotropin (HCG) Market Forecast by Regions
- 12.1.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Regions 2019-2025
12.2 Human Chorionic Gonadotropin (HCG) Market Forecast by Product
- 12.2.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Product 2019-2025
- 12.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Product 2019-2025
12.3 Human Chorionic Gonadotropin (HCG) Market Forecast by End User
12.4 North America Human Chorionic Gonadotropin (HCG) Forecast
12.5 Europe Human Chorionic Gonadotropin (HCG) Forecast
12.6 Asia Pacific Human Chorionic Gonadotropin (HCG) Forecast
12.7 Central & South America Human Chorionic Gonadotropin (HCG) Forecast
12.8 Middle East and Africa Human Chorionic Gonadotropin (HCG) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Human Chorionic Gonadotropin (HCG) Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.
The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.
The global Human Chorionic Gonadotropin (HCG) market is valued at 390 million US$ in 2018 and will reach 620 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Chorionic Gonadotropin (HCG) market based on company, product type, end user and key regions.

This report studies the global market size of Human Chorionic Gonadotropin (HCG) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Chorionic Gonadotropin (HCG) in these regions.
This research report categorizes the global Human Chorionic Gonadotropin (HCG) market by top players/brands, region, type and end user. This report also studies the global Human Chorionic Gonadotropin (HCG) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG, LLC
Scrippslabs
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna

Market size by Product
Natural Source Extraction
Recombinant DNA Technology
Market size by End User
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Human Chorionic Gonadotropin (HCG) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Human Chorionic Gonadotropin (HCG) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Human Chorionic Gonadotropin (HCG) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Human Chorionic Gonadotropin (HCG) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Human Chorionic Gonadotropin (HCG) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Chorionic Gonadotropin (HCG) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.